Cargando…
Alpha‐synuclein fibrils amplified from multiple system atrophy and Parkinson's disease patient brain spread after intracerebral injection into mouse brain
Parkinson's disease (PD), multiple system atrophy (MSA), and dementia with Lewy bodies (DLB) are neurodegenerative disorders with alpha‐synuclein (α‐syn) aggregation pathology. Different strains of α‐syn with unique properties are suggested to cause distinct clinical and pathological manifestat...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10467043/ https://www.ncbi.nlm.nih.gov/pubmed/37485772 http://dx.doi.org/10.1111/bpa.13196 |
_version_ | 1785099026524274688 |
---|---|
author | Zhang, Shuyu Dauer, Karina Strohäker, Timo Tatenhorst, Lars Caldi Gomes, Lucas Mayer, Simon Jung, Byung Chul Kim, Woojin S. Lee, Seung‐Jae Becker, Stefan Liesche‐Starnecker, Friederike Zweckstetter, Markus Lingor, Paul |
author_facet | Zhang, Shuyu Dauer, Karina Strohäker, Timo Tatenhorst, Lars Caldi Gomes, Lucas Mayer, Simon Jung, Byung Chul Kim, Woojin S. Lee, Seung‐Jae Becker, Stefan Liesche‐Starnecker, Friederike Zweckstetter, Markus Lingor, Paul |
author_sort | Zhang, Shuyu |
collection | PubMed |
description | Parkinson's disease (PD), multiple system atrophy (MSA), and dementia with Lewy bodies (DLB) are neurodegenerative disorders with alpha‐synuclein (α‐syn) aggregation pathology. Different strains of α‐syn with unique properties are suggested to cause distinct clinical and pathological manifestations resulting in PD, MSA, or DLB. To study individual α‐syn spreading patterns, we injected α‐syn fibrils amplified from brain homogenates of two MSA patients and two PD patients into the brains of C57BI6/J mice. Antibody staining against pS129‐α‐syn showed that α‐syn fibrils amplified from the brain homogenates of the four different patients caused different levels of α‐syn spreading. The strongest α‐syn pathology was triggered by α‐syn fibrils of one of the two MSA patients, followed by comparable pS129‐α‐syn induction by the second MSA and one PD patient material. Histological analysis using an antibody against Iba1 further showed that the formation of pS129‐α‐syn is associated with increased microglia activation. In contrast, no differences in dopaminergic neuron numbers or co‐localization of α‐syn in oligodendrocytes were observed between the different groups. Our data support the spreading of α‐syn pathology in MSA, while at the same time pointing to spreading heterogeneity between different patients potentially driven by individual patient immanent factors. |
format | Online Article Text |
id | pubmed-10467043 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-104670432023-08-31 Alpha‐synuclein fibrils amplified from multiple system atrophy and Parkinson's disease patient brain spread after intracerebral injection into mouse brain Zhang, Shuyu Dauer, Karina Strohäker, Timo Tatenhorst, Lars Caldi Gomes, Lucas Mayer, Simon Jung, Byung Chul Kim, Woojin S. Lee, Seung‐Jae Becker, Stefan Liesche‐Starnecker, Friederike Zweckstetter, Markus Lingor, Paul Brain Pathol Research Articles Parkinson's disease (PD), multiple system atrophy (MSA), and dementia with Lewy bodies (DLB) are neurodegenerative disorders with alpha‐synuclein (α‐syn) aggregation pathology. Different strains of α‐syn with unique properties are suggested to cause distinct clinical and pathological manifestations resulting in PD, MSA, or DLB. To study individual α‐syn spreading patterns, we injected α‐syn fibrils amplified from brain homogenates of two MSA patients and two PD patients into the brains of C57BI6/J mice. Antibody staining against pS129‐α‐syn showed that α‐syn fibrils amplified from the brain homogenates of the four different patients caused different levels of α‐syn spreading. The strongest α‐syn pathology was triggered by α‐syn fibrils of one of the two MSA patients, followed by comparable pS129‐α‐syn induction by the second MSA and one PD patient material. Histological analysis using an antibody against Iba1 further showed that the formation of pS129‐α‐syn is associated with increased microglia activation. In contrast, no differences in dopaminergic neuron numbers or co‐localization of α‐syn in oligodendrocytes were observed between the different groups. Our data support the spreading of α‐syn pathology in MSA, while at the same time pointing to spreading heterogeneity between different patients potentially driven by individual patient immanent factors. John Wiley and Sons Inc. 2023-07-24 /pmc/articles/PMC10467043/ /pubmed/37485772 http://dx.doi.org/10.1111/bpa.13196 Text en © 2023 The Authors. Brain Pathology published by John Wiley & Sons Ltd on behalf of International Society of Neuropathology. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Articles Zhang, Shuyu Dauer, Karina Strohäker, Timo Tatenhorst, Lars Caldi Gomes, Lucas Mayer, Simon Jung, Byung Chul Kim, Woojin S. Lee, Seung‐Jae Becker, Stefan Liesche‐Starnecker, Friederike Zweckstetter, Markus Lingor, Paul Alpha‐synuclein fibrils amplified from multiple system atrophy and Parkinson's disease patient brain spread after intracerebral injection into mouse brain |
title | Alpha‐synuclein fibrils amplified from multiple system atrophy and Parkinson's disease patient brain spread after intracerebral injection into mouse brain |
title_full | Alpha‐synuclein fibrils amplified from multiple system atrophy and Parkinson's disease patient brain spread after intracerebral injection into mouse brain |
title_fullStr | Alpha‐synuclein fibrils amplified from multiple system atrophy and Parkinson's disease patient brain spread after intracerebral injection into mouse brain |
title_full_unstemmed | Alpha‐synuclein fibrils amplified from multiple system atrophy and Parkinson's disease patient brain spread after intracerebral injection into mouse brain |
title_short | Alpha‐synuclein fibrils amplified from multiple system atrophy and Parkinson's disease patient brain spread after intracerebral injection into mouse brain |
title_sort | alpha‐synuclein fibrils amplified from multiple system atrophy and parkinson's disease patient brain spread after intracerebral injection into mouse brain |
topic | Research Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10467043/ https://www.ncbi.nlm.nih.gov/pubmed/37485772 http://dx.doi.org/10.1111/bpa.13196 |
work_keys_str_mv | AT zhangshuyu alphasynucleinfibrilsamplifiedfrommultiplesystematrophyandparkinsonsdiseasepatientbrainspreadafterintracerebralinjectionintomousebrain AT dauerkarina alphasynucleinfibrilsamplifiedfrommultiplesystematrophyandparkinsonsdiseasepatientbrainspreadafterintracerebralinjectionintomousebrain AT strohakertimo alphasynucleinfibrilsamplifiedfrommultiplesystematrophyandparkinsonsdiseasepatientbrainspreadafterintracerebralinjectionintomousebrain AT tatenhorstlars alphasynucleinfibrilsamplifiedfrommultiplesystematrophyandparkinsonsdiseasepatientbrainspreadafterintracerebralinjectionintomousebrain AT caldigomeslucas alphasynucleinfibrilsamplifiedfrommultiplesystematrophyandparkinsonsdiseasepatientbrainspreadafterintracerebralinjectionintomousebrain AT mayersimon alphasynucleinfibrilsamplifiedfrommultiplesystematrophyandparkinsonsdiseasepatientbrainspreadafterintracerebralinjectionintomousebrain AT jungbyungchul alphasynucleinfibrilsamplifiedfrommultiplesystematrophyandparkinsonsdiseasepatientbrainspreadafterintracerebralinjectionintomousebrain AT kimwoojins alphasynucleinfibrilsamplifiedfrommultiplesystematrophyandparkinsonsdiseasepatientbrainspreadafterintracerebralinjectionintomousebrain AT leeseungjae alphasynucleinfibrilsamplifiedfrommultiplesystematrophyandparkinsonsdiseasepatientbrainspreadafterintracerebralinjectionintomousebrain AT beckerstefan alphasynucleinfibrilsamplifiedfrommultiplesystematrophyandparkinsonsdiseasepatientbrainspreadafterintracerebralinjectionintomousebrain AT lieschestarneckerfriederike alphasynucleinfibrilsamplifiedfrommultiplesystematrophyandparkinsonsdiseasepatientbrainspreadafterintracerebralinjectionintomousebrain AT zweckstettermarkus alphasynucleinfibrilsamplifiedfrommultiplesystematrophyandparkinsonsdiseasepatientbrainspreadafterintracerebralinjectionintomousebrain AT lingorpaul alphasynucleinfibrilsamplifiedfrommultiplesystematrophyandparkinsonsdiseasepatientbrainspreadafterintracerebralinjectionintomousebrain |